Taylor Wessing

Never stand still. We push forward to develop, grow and shape – ourselves, our work and our future. Never stand still. We strengthen our strengths. For us, that means focus. We concentrate on what we do best. Internationally experienced. With many years of expertise. “Never stand still” – for us, far more than just a slogan. It is our mindset. How we work and how we lead our clients to success.

The EU AI Act is now law. If you're using AI in your life sciences business, you need to ensure you're compliant. Failing to do so could mean severe financial penalties, reputational damage, and losing customer trust. But what legal areas do you need to manage when it comes to AI? Our new guide covers the main issues you need to focus on and includes information on: · common legal challenges in areas like IP, M&A, and regulation · the top AI use cases for life sciences · how we've helped life sciences clients turn AI opportunity into a commercial reality.

The EU AI Act is now law, and life sciences businesses must act to ensure they're compliant. Failing to do so could lead to severe financial penalties and reputational damage. Our new guide sets out the main areas that you need to focus on when it comes to adopting, integrating, and investing in AI. It includes information on: · common legal challenges in areas like IP, M&A, and regulation · the top AI use cases for life sciences · how we've helped life sciences clients turn AI opportunity into a commercial reality.

AI is reshaping the life sciences sector and ushering in a new era of innovation and efficiency. But if you're implementing this transformational technology, you'll also need to manage the legal challenges that come with it. Our new guide covers the key legal and commercial issues you need to consider when adopting, integrating, and investing in AI, including: · common challenges in areas like IP, M&A, and regulation · the top AI use cases for life sciences · how we've helped life sciences clients turn AI opportunity into a commercial reality.

AI is helping life sciences businesses to accelerate drug discovery, transform diagnostics, and tailor patient care. But to ensure it's adopted ethically and transparently, the EU has introduced the AI Act. There are strict new requirements for businesses, and you need to ensure you're compliant. Our new guide covers the key areas life sciences businesses need to consider when it comes to AI, including information on: · common legal challenges in areas like IP, M&A, and regulation · the top AI use cases for life sciences · how we've helped clients to implement AI safely.

Explore the anatomy of successful cross-border deals in our new Dealonomics report. Created in collaboration with Bayes Business School, it covers why having a clear rationale, thoughtful deal structuring, a long-term plan, and advisers who can help navigate regulatory complexity are important. Discover how structure, strategic clarity, and post-deal discipline drive success in global M&A: https://bit.ly/4lYWKCO #Dealonomics #MergersAndAcquisitions